Shinya Tokuhiro1, 2, Ryo Yamada1, Xiaotian Chang1, Akari Suzuki1, Yuta Kochi1, 3, Tetsuji Sawada3, Masakatsu Suzuki2, Miyuki Nagasaki2, Masahiko Ohtsuki2, Mitsuru Ono2, Hidehiko Furukawa2, Masakazu Nagashima4, Shinichi Yoshino4, Akihiko Mabuchi5, Akihiro Sekine6, Susumu Saito6, Atsushi Takahashi7, Tatsuhiko Tsunoda7, Yusuke Nakamura8, 9
& Kazuhiko Yamamoto1, 31
Laboratory for Rheumatic Diseases, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa 230-0045, Japan.
2
Laboratory for Rheumatic Diseases, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), 1-7-22, Suehiro-cho, Tsurumi-ku, Sankyo, Tokyo, Japan.
3
Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
4
Department of Joint Disease and Rheumatism, Nippon Medical School, Tokyo, Japan.
5
Laboratory for Bone and Joint Diseases, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo, Japan.
6
Laboratory for Genotyping, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan.
7
Laboratory for Medical Informatics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan.
8
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
9
Research Group for Personalized Medicine, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo, Japan.
Correspondence should be addressed to Ryo Yamada ryamada@src.riken.go.jp
